CVS lifts full-year adjusted EPS guidance to at least $8.20

The size of the beats matters more than the guidance raise itself: quarterly adjusted EPS and revenue both cleared expectations by wide margins, and the full-year floor now sits above the prior ceiling. That pattern points to underlying momentum rather than a one-off accounting lift, though the item gives no segment detail to confirm where the strength originates. For readers tracking healthcare-adjacent and defensive names, the open question is whether this reflects broad demand resilience or a narrower driver that may not repeat — and whether peers follow with similarly outsized beats.